Efficacy of onabotulinum toxin A injection in pediatric patients with non-neurogenic detrusor overactivity

Neurourology and Urodynamics ◽

10.1002/nau.23240 ◽

2017 ◽

Vol 36 (8) ◽

pp. 2078-2082 ◽

Author(s):

Omer Bayrak ◽

Erkan Sadioglu ◽

Haluk Sen ◽

Kazim Dogan ◽

Sakip Erturhan ◽

...

Keyword(s):

Detrusor Overactivity ◽

Pediatric Patients ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

Faculty Opinions recommendation of Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727540395.793531521 ◽

2017 ◽

Author(s):

Peter Rosier

Keyword(s):

Detrusor Overactivity ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

PD1-04 DETRUSOR INJECTIONS OF ONABOTULINUM TOXIN A (BOTOX®) VERSUS ABOBOTULINUM TOXIN A (DYSPORT®) IN THE MANAGEMENT OF NEUROGENIC DETRUSOR OVERACTIVITY : A CASE CONTROL STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.199 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Benoit Peyronnet ◽

Castel-Lacanal Evelyne ◽

Roumiguie Mathieu ◽

Marque Philippe ◽

Rischmann Pascal ◽

...

Keyword(s):

Detrusor Overactivity ◽

Case Control Study ◽

Case Control ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A ◽

Download Full-text

Intradetrusor injections of onabotulinum toxin A (Botox®) 300 U or 200 U versus abobotulinum toxin A (Dysport®) 750 U in the management of neurogenic detrusor overactivity: A case control study

Neurourology and Urodynamics ◽

10.1002/nau.23009 ◽

2016 ◽

Vol 36 (3) ◽

pp. 734-739 ◽

Author(s):

Benoit Peyronnet ◽

Evelyne Castel-Lacanal ◽

Mathieu Roumiguie ◽

Lucie Even ◽

Philippe Marque ◽

...

Keyword(s):

Detrusor Overactivity ◽

Case Control Study ◽

Case Control ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A ◽

Download Full-text

Onabotulinum Toxin A: A Therapeutic Option for Refractory Neurogenic Detrusor Overactivity and Idiopathic Overactive Bladder

Urologic Nursing ◽

10.7257/1053-816x.2014.34.4.165 ◽

2014 ◽

Vol 34 (4) ◽

pp. 165 ◽

Author(s):

Pamela Ellsworth ◽

Michelle Travis

Keyword(s):

Overactive Bladder ◽

Detrusor Overactivity ◽

Therapeutic Option ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

Re: Switch to Abobotulinum Toxin A May be Useful in the Treatment of Neurogenic Detrusor Overactivity when Intradetrusor Injections of Onabotulinum Toxin A Failed

The Journal of Urology ◽

10.1097/01.ju.0000553734.37603.c9 ◽

2019 ◽

Vol 201 (3) ◽

pp. 451-452

Author(s):

Alan J. Wein

Keyword(s):

Detrusor Overactivity ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

Intradetrusor Injections of Onabotulinum Toxin-A in Children With Urinary Incontinence due to Neurogenic Detrusor Overactivity Refractory to Antimuscarinic Treatment

Korean Journal of Urology ◽

10.4111/kju.2014.55.4.281 ◽

2014 ◽

Vol 55 (4) ◽

pp. 281 ◽

Author(s):

Tufan Tarcan ◽

Cem Akbal ◽

Çağri A. Şekerci ◽

Tuncay Top ◽

Ferruh Şimşek

Keyword(s):

Urinary Incontinence ◽

Detrusor Overactivity ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

PD36-10 LONG TERM FOLLOW-UP REVEALS A LOW PERSISTENCE RATE OF ABOBOTULINUM TOXIN A AND ONABOTULINUM TOXIN A INJECTIONS FOR NEUROGENIC DETRUSOR OVERACTIVITY.

The Journal of Urology ◽

10.1016/j.juro.2018.02.1733 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Maximilien BARON ◽

Benoit Peyronnet ◽

Annabelle Auble ◽

Gabriel Miget ◽

Juliette Hascoet ◽

...

Keyword(s):

Detrusor Overactivity ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Persistence Rate ◽

Onabotulinum Toxin A ◽

Long Term Follow Up

Download Full-text

Efficacy and safety of three active doses of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in children: Results of a randomized controlled clinical trial

European Urology Open Science ◽

10.1016/s2666-1683(20)33351-6 ◽

2020 ◽

Vol 19 ◽

pp. e1147

Author(s):

P. Hoebeke ◽

P.F. Austin ◽

I. Franco ◽

E. Dobremez ◽

P. Kroll ◽

...

Keyword(s):

Clinical Trial ◽

Detrusor Overactivity ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Neurogenic Detrusor Overactivity ◽

Randomized Controlled Clinical Trial ◽

Toxin A ◽

Randomized Controlled ◽

Onabotulinum Toxin A

Download Full-text

Long-term real life efficacy of onabotulinum toxin A for the treatment of neurogenic detrusor overactivity in a population using intermittent self-catheterization

Annals of Physical and Rehabilitation Medicine ◽

10.1016/j.rehab.2016.07.232 ◽

2016 ◽

Vol 59 ◽

pp. e105 ◽

Author(s):

Charles Joussain ◽

Mélanie Popoff ◽

Véronique Phé ◽

Alexia Even ◽

Laetitia Falcou ◽

...

Keyword(s):

Detrusor Overactivity ◽

Real Life ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text

Clinical and Urodynamic Results of Repeated Intradetrusor Onabotulinum Toxin A Injections in Refractory Neurogenic Detrusor Overactivity: Up to 5 Injections in a Cohort of Children With Myelodysplasia

Urology ◽

10.1016/j.urology.2017.09.005 ◽

2018 ◽

Vol 111 ◽

pp. 168-175 ◽

Author(s):

Cagri Akin Sekerci ◽

Yiloren Tanidir ◽

Asgar Garayev ◽

Cem Akbal ◽

Tufan Tarcan ◽

...

Keyword(s):

Detrusor Overactivity ◽

Neurogenic Detrusor Overactivity ◽

Toxin A ◽

Onabotulinum Toxin A

Download Full-text